According to Roivant Sciences's latest financial reports the company has ยฃ3.96 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-03-31 | ยฃ5.17 B | 282.4% |
2023-03-31 | ยฃ1.35 B | -13.68% |
2022-03-31 | ยฃ1.56 B | 4.9% |
2021-03-31 | ยฃ1.49 B |